Clinical Trials Browser

Kidney Neoplasms × Irinotecan × Genitourinary × Clear all

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

NCT05384821 2026-03-18

MetroWilms

Phase 1/2 Recruiting

28 enrolled

Genitourinary

Kidney Neoplasms, Wilms Tumor

NCT00089102 2018-07-16

Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer

Phase 2 Terminated

9 enrolled 8 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00401128 2017-04-20

Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

Phase 2 Completed

9 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00004095 2017-04-18

Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Completed

38 enrolled

BreastGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

Clinical Trials

9-ING-41 in Patients With Advanced Cancers

MetroWilms

Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer

Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors